AVITA Medical to Announce Second Quarter 2024 Financial Results #WoundCare #RegenerativeMedicine #SprayOnSkin $RCEL $AVH bit.ly/3Y0DWds
AVITA Medical
Medical Device
Santa Clarita, California 17,144 followers
Transforming lives by providing innovative ways of healing skin.
About us
AVITA Medical (NASDAQ: RCEL, ASX:AVH) is a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration. At the forefront of our platform is the RECELL® System, approved by the U.S. Food and Drug Administration for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. RECELL harnesses the regenerative properties of a patient’s own skin to create Spray-On Skin™ Cells, delivering a transformative solution at the point-of-care. This breakthrough technology serves as the catalyst for a new treatment paradigm enabling improved clinical outcomes. AVITA Medical also holds the exclusive rights to market, sell, and distribute PermeaDerm®, a Biosynthetic Wound Matrix, in the United States.
- Website
-
https://avitamedical.com/
External link for AVITA Medical
- Industry
- Medical Device
- Company size
- 201-500 employees
- Headquarters
- Santa Clarita, California
- Type
- Public Company
- Founded
- 2008
- Specialties
- Regenerative Medicine, Chronic Wounds, Plastic Surgery, General Surgery, Acne Scar, Scar Revisions, Dermatology, and Burn & Trauma Surgeon
Locations
-
Primary
Get directions
28159 Avenue Stanford
Santa Clarita, California, US
Employees at AVITA Medical
Updates
-
AVITA Medical Achieves Milestone with First Case Using RECELL GO @DoctorsAugusta #RECELLGO #SprayOnSkin #WoundCare #RegenerativeMedicine #FDAApproval $RCEL $AVH bit.ly/3yWQibK
-
Breaking News: FDA Approves RECELL GO™! Our next-gen device streamlines the preparation of Spray-On Skin™ Cells, delivering transformative point-of-care treatment to patients with thermal burn wounds and full-thickness skin defects. #RECELLGO #SprayOnSkin #WoundCare #RegenerativeMedicine #FDAApproval $RCEL $AVH bit.ly/3V5m7qx
-
-
AVITA Medical is proud to sponsor and exhibit the RECELL® System at the AAD Annual Meeting, 2024 #vitiligo #skinrepigmentation #RECELL #SprayonSkin #ADD2024 @AADmember https://buff.ly/3PckrJF
-
-
AVITA Medical is proud to sponsor and exhibit the RECELL® System at the 20th Annual SOCS Scientific Symposium #vitiligo #skinrepigmentation #RECELL #SprayonSkin #GVFsymposium @StepUp4Vitiligo https://buff.ly/49D118T
-
-
AVITA Medical is proud to sponsor and exhibit the RECELL® System at the 20th Annual SOCS Scientific Symposium #vitiligo #skinrepigmentation #RECELL #SprayonSkin #GVFsymposium @StepUp4Vitiligo https://buff.ly/49D118T
-
-
AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement #SprayonSkin #RECELL #regeneration #skinrestoration $RCEL $AVH https://buff.ly/48DUJEF
-
-
AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference #SprayonSkin #RECELL #regeneration #skinrestoration $RCEL $AVH https://buff.ly/3TeaD42
-
-
AVITA Medical to Host Investor Webinar Briefing #SprayonSkin #RECELL #regeneration #skinrestoration $RCEL $AVH https://buff.ly/3UQ5kcs
-
-
AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance #SprayonSkin #RECELL #regeneration #skinrestoration $RCEL $AVH https://buff.ly/42N1Lpm
-